Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment
Sign Up to like & getrecommendations! Published in 2018 at "Liver Cancer"
DOI: 10.1159/000489021
Abstract: Objective: Programmed death-ligand 1 (PD-L1) expression in the tumor microenvironment (TME) has been reported to be related to prognosis in patients with hepatocellular carcinoma (HCC) after hepatectomy. The impact of sorafenib on PD-L1 expression in… read more here.
Keywords: sorafenib treatment; post sorafenib; sorafenib; hcc tissues ... See more keywords